AMNIGRAFT Wound Allograft is indicated for use as a wound covering for dermal ulcers and defects. Amnigraft reduces scar tissue
formation, modulates inflammation in the surgical site, enhances healing, and acts as a barrier.
Human amniotic membrane comprises the innermost layer of the placenta and lines the amniotic cavity. Other forms of the same type of placental tissue have been used for 100 years; this type of tissue is becoming a standard wound treatment for chronic wounds. Amnigraft is rich with the basic components necessary for tissue repair and wound healing. They contain collagen substrates, growth factors, amino acids, carbohydrates, and cytokines, which are known to facilitate migration and proliferation cells to the site of injury and help construct a natural scaffold on which new tissue growth can occur. Amnigraft is processed through the process that combines cleaning, dehydration and sterilization, and it may be stored at ambient conditions for up to 3 years. The proprietary protects the delicate scaffold during processing, leaving an intact collagen matrix. The result is a durable graft with natural barrier properties to optimize surgical performance and ease of use.